Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Market Update 23 May

Bell Direct
May 23, 2016

Technical Insights – Event Screener

Bell Direct
May 20, 2016

Technical Insights – Watchlists

Bell Direct
May 20, 2016

Market Update 11 May 2016

Bell Direct
May 11, 2016

Market Update 4 May 2016

Bell Direct
May 4, 2016

Market Update

Julia Lee
April 28, 2016

Under the Radar Report: Blue sky stocks

Richard Hemming
April 22, 2016

Three Quintessential Stocks

Bell Direct
April 13, 2016

Bell Potter Yield Stocks

Bell Direct
April 12, 2016